Forwardly Inc (FORW)

[NOBO]

Funding for the new LifeAir G1 prototype is being raised by Forwardly through the exercise of warrants issued to purchasers of a series of debentures issued in 2019 with an aggregate total of $300,000 (the "2020 debentures"), as well as purchasers of a new series of non-toxic debentures for an aggregate total of up to $1 million. These new debentures are convertible to common stock at $.012 and set to mature in March 2022 (the "2022 debentures").

George Sharp commented, "With the business world being slowed to a crawl as a result of the current pandemic, Forwardly management deemed it more expeditious to raise funds privately to enable the development of the next generation of LifeAir G1, rather than wait for the SEC's approval of the Regulation A+ application and the subsequent time required to fund. We found our private funders to be more than eager to participate, by exercising outstanding warrants and purchasing our new series of debentures. I am proud that our private funding sources continue to support our endeavors.

Further information about Forwardly's endeavors can be obtained from the company's website www.ForwardlyPlaced.com

https://www.newsfilecorp.com/release/62854/Forwardly-Inc.-Raises-500000-Privately-Will-Fund-Development-of-Ligand-Global-Innovations-Latest-Prototype-of-LifeAir-G1?k=Forwardly,%20Inc